GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics ...

PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting ...

GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's global mRNA platform and reinforcing ...

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...

PISCATAWAY, N.J., March 12, 2024 /PRNewswire/ -- On March 11, 2024, GenScript Biotech Corporation (HK.1548), a world's leading technology and service provider of life science R&D and manufacturing, ...

Genscript Biotech ( (HK:1548)) just unveiled an announcement. Genscript Biotech reported a sharp acceleration in operating performance for 2025, with revenue from continuing operations surging 61.4% ...

(Reuters) -The U.S. House of Representatives committee on China on Tuesday sent a letter to the directors of the FBI and national intelligence, renewing its concerns about GenScript Biotechnology's ...

In the world of advanced medical research, the convergence of synthetic biology and cellular immunotherapy has inaugurated a new era in field of cancer treatment. Simultaneously, life science research ...

PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy ...

GenScript currently has good financial health, with just USD 46 million of debt in 2020 and USD 629 million of cash. We think this provides it enough cash to spend over USD 500 million for research ...

Although these are uncertain times, one thing I am certain of is that with synthetic biology and life sciences companies stepping in to help from all around the world, scientists like Liusong Yin may ...

GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction. Legend Biotech continues to invest in R&D to expand the ...